ADMA BIOLOGICS, INC. Increase (Decrease) in Accounts Payable
ADMA BIOLOGICS, INC. (ADMA) reported Increase (Decrease) in Accounts Payable of $8.85 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-05
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was $10.08M, a 8.76% increase year-over-year.
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was -$1.23M, a 968.31% decline year-over-year.
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$2.20M, a 155.89% decline year-over-year.
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$4.88M, a 401.36% decline year-over-year.
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for fiscal 2025 was $2.33M, a 43.86% decline from fiscal 2024.
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for fiscal 2024 was $4.15M, a 8.10% increase from fiscal 2023.
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for fiscal 2023 was $3.84M, a 379.88% increase from fiscal 2022.
- ADMA BIOLOGICS, INC. increase (decrease) in accounts payable for fiscal 2022 was $800.00K, a 41.00% decline from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 3 month as first filed | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 6 month as first filed | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 9 month as first filed | Increase (Decrease) in Accounts Payable 12 month | Increase (Decrease) in Accounts Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $10.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $8.85M 10-Q · filed 2026-08-05 | $6.64M derived: sum of 3 quarters · filed 2026-08-05 | $1.77M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$1.23M 10-Q · filed 2026-05-06 | -$3.44M derived: sum of 2 quarters · filed 2026-05-06 | -$8.31M derived: sum of 3 quarters · filed 2026-05-06 | $955.00K derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$2.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$7.08M derived: sum of 2 quarters · filed 2026-02-25 | $2.19M derived: sum of 3 quarters · filed 2026-08-05 | $2.33M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | -$4.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.39M derived: sum of 2 quarters · filed 2026-08-05 | $4.53M 10-Q · filed 2025-11-05 | $8.47M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $9.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $9.41M 10-Q · filed 2026-08-05 | $13.35M derived: sum of 3 quarters · filed 2026-08-05 | $14.97M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | $142.00K 10-Q · filed 2026-05-06 | $4.08M derived: sum of 2 quarters · filed 2026-05-06 | $5.70M derived: sum of 3 quarters · filed 2026-05-06 | $3.85M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | $3.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $5.56M derived: sum of 2 quarters · filed 2026-02-25 | $3.70M derived: sum of 3 quarters · filed 2026-02-25 | $4.15M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$239.00K derived: sum of 2 quarters · filed 2025-11-05 | $208.00K 10-Q · filed 2025-11-05 | $5.20M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | -$1.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.41M 10-Q · filed 2025-08-06 | $3.58M derived: sum of 3 quarters · filed 2026-02-25 | $3.57M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $447.00K 10-Q · filed 2025-05-07 | $5.44M derived: sum of 2 quarters · filed 2026-02-25 | $5.43M derived: sum of 3 quarters · filed 2026-02-25 | $4.56M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $4.99M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.98M derived: sum of 2 quarters · filed 2026-02-25 | $4.11M derived: sum of 3 quarters · filed 2026-02-25 | $3.84M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$882.00K derived: sum of 2 quarters · filed 2024-11-07 | -$1.16M 10-Q · filed 2024-11-07 | -$1.15M 10-Q · filed 2023-11-08 | -$13.12M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | -$872.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.15M 10-Q · filed 2024-08-08 | -$1.14M 10-Q · filed 2023-08-09 | -$13.11M derived: sum of 3 quarters · filed 2025-03-18 | $696.36K derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | -$273.00K 10-Q · filed 2024-05-09 | -$272.90K 10-Q · filed 2023-05-10 | -$12.24M derived: sum of 2 quarters · filed 2025-03-18 | $1.57M derived: sum of 3 quarters · filed 2025-03-18 | -$1.16M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | -$11.97M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.84M derived: sum of 2 quarters · filed 2025-03-18 | -$885.72K derived: sum of 3 quarters · filed 2025-03-18 | $800.00K 10-K · filed 2025-03-18 | $799.98K 10-K · filed 2023-03-23 | |||
| 2022-09-30 | $13.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $11.08M derived: sum of 2 quarters · filed 2023-11-08 | $12.77M 10-Q · filed 2023-11-08 | $7.92M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-06-30 | -$2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$1.04M 10-Q · filed 2023-08-09 | -$5.89M derived: sum of 3 quarters · filed 2024-02-28 | $5.22M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2022-03-31 | $1.69M 10-Q · filed 2023-05-10 | -$3.17M derived: sum of 2 quarters · filed 2024-02-28 | $7.95M derived: sum of 3 quarters · filed 2024-02-28 | $1.96M derived: sum of 4 quarters · filed 2024-02-28 | ||||
| 2021-12-31 | -$4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $6.26M derived: sum of 2 quarters · filed 2024-02-28 | $276.86K derived: sum of 3 quarters · filed 2024-02-28 | $1.36M 10-K · filed 2024-02-28 | $1.36M 10-K · filed 2022-03-24 | |||
| 2021-09-30 | $11.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $5.13M derived: sum of 2 quarters · filed 2022-11-09 | $6.21M 10-Q · filed 2022-11-09 | $9.30M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | -$5.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$4.91M 10-Q · filed 2022-08-10 | -$1.81M derived: sum of 3 quarters · filed 2022-08-10 | -$742.20K derived: sum of 4 quarters · filed 2022-08-10 | ||||
| 2021-03-31 | $1.08M 10-Q · filed 2022-05-11 | $4.17M derived: sum of 2 quarters · filed 2022-05-11 | $5.24M derived: sum of 3 quarters · filed 2022-05-11 | $3.00M derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $4.16M derived: sum of 2 quarters · filed 2022-03-24 | $1.92M derived: sum of 3 quarters · filed 2022-03-24 | $1.90M 10-K · filed 2022-03-24 | ||||
| 2020-09-30 | $1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$1.17M derived: sum of 2 quarters · filed 2021-11-10 | -$1.19M 10-Q · filed 2021-11-10 | -$980.13K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | -$2.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$2.26M 10-Q · filed 2021-08-11 | -$2.05M derived: sum of 3 quarters · filed 2021-08-11 | $121.52K derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | -$22.36K 10-Q · filed 2021-05-12 | $192.33K derived: sum of 2 quarters · filed 2021-05-12 | $2.36M derived: sum of 3 quarters · filed 2021-05-12 | $3.67M derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | $214.69K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $2.39M derived: sum of 2 quarters · filed 2021-03-25 | $3.69M derived: sum of 3 quarters · filed 2021-03-25 | $3.27M 10-K · filed 2021-03-25 | ||||
| 2019-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.48M derived: sum of 2 quarters · filed 2020-11-05 | $3.06M 10-Q · filed 2020-11-05 | $3.69M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $887.75K 10-Q · filed 2020-08-05 | $1.52M derived: sum of 3 quarters · filed 2020-08-05 | $3.69M derived: sum of 4 quarters · filed 2020-08-05 | ||||
| 2019-03-31 | -$420.60K 10-Q · filed 2020-05-06 | $212.11K derived: sum of 2 quarters · filed 2020-05-06 | $2.38M derived: sum of 3 quarters · filed 2020-05-06 | -$238.33K derived: sum of 4 quarters · filed 2020-05-06 | ||||
| 2018-12-31 | $632.71K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $2.80M derived: sum of 2 quarters · filed 2020-03-13 | $182.27K derived: sum of 3 quarters · filed 2020-03-13 | -$20.48K 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $2.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$450.44K derived: sum of 2 quarters · filed 2019-11-06 | -$653.19K 10-Q · filed 2019-11-06 | -$3.07M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2018-06-30 | -$2.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$2.82M 10-Q · filed 2019-08-08 | -$5.24M derived: sum of 3 quarters · filed 2019-08-08 | -$1.77M derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | -$202.75K 10-Q · filed 2019-05-08 | -$2.62M derived: sum of 2 quarters · filed 2019-05-08 | $846.29K derived: sum of 3 quarters · filed 2019-05-08 | $1.27M derived: sum of 4 quarters · filed 2019-05-08 | ||||
| 2017-12-31 | -$2.42M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $1.05M derived: sum of 2 quarters · filed 2019-03-13 | $1.47M derived: sum of 3 quarters · filed 2019-03-13 | $2.81M 10-K · filed 2019-03-13 | ||||
| 2017-09-30 | $3.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $3.89M derived: sum of 2 quarters · filed 2018-11-09 | $5.23M 10-Q · filed 2018-11-09 | $5.02M derived: sum of 4 quarters · filed 2018-11-09 | ||||
| 2017-06-30 | $423.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $1.76M 10-Q · filed 2018-08-10 | $1.55M derived: sum of 3 quarters · filed 2018-08-10 | $1.21M derived: sum of 4 quarters · filed 2018-08-10 | ||||
| 2017-03-31 | $1.34M 10-Q · filed 2018-05-14 | $1.13M derived: sum of 2 quarters · filed 2018-05-14 | $782.50K derived: sum of 3 quarters · filed 2018-05-14 | $1.44M derived: sum of 4 quarters · filed 2018-05-14 | ||||
| 2016-12-31 | -$212.54K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | -$557.27K derived: sum of 2 quarters · filed 2018-03-29 | $99.77K derived: sum of 3 quarters · filed 2018-03-29 | $476.83K 10-K · filed 2018-03-29 | ||||
| 2016-09-30 | -$344.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $312.31K derived: sum of 2 quarters · filed 2017-11-03 | $689.37K 10-Q · filed 2017-11-03 | $580.46K derived: sum of 4 quarters · filed 2017-11-03 | ||||
| 2016-06-30 | $657.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $1.03M 10-Q · filed 2017-08-11 | $925.19K derived: sum of 3 quarters · filed 2017-08-11 | $1.54M derived: sum of 4 quarters · filed 2017-08-11 | ||||
| 2016-03-31 | $377.06K 10-Q · filed 2017-05-12 | $268.16K derived: sum of 2 quarters · filed 2017-05-12 | $885.56K derived: sum of 3 quarters · filed 2017-05-12 | $649.92K derived: sum of 4 quarters · filed 2017-05-12 | ||||
| 2015-12-31 | -$108.91K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $508.50K derived: sum of 2 quarters · filed 2017-02-24 | $272.86K derived: sum of 3 quarters · filed 2017-02-24 | $202.99K 10-K · filed 2017-02-24 | $308.66K 10-K · filed 2016-03-23 | |||
| 2015-09-30 | $617.40K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $381.76K derived: sum of 2 quarters · filed 2016-11-10 | $311.90K 10-Q · filed 2016-11-10 | -$360.13K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | -$235.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-12 | -$305.51K 10-Q · filed 2016-08-12 | -$977.53K derived: sum of 3 quarters · filed 2016-08-12 | -$873.52K derived: sum of 4 quarters · filed 2016-08-12 | ||||
| 2015-03-31 | -$69.87K 10-Q · filed 2016-05-13 | -$741.89K derived: sum of 2 quarters · filed 2016-05-13 | -$637.88K derived: sum of 3 quarters · filed 2016-05-13 | -$1.06M derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | -$672.02K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | -$568.01K derived: sum of 2 quarters · filed 2016-03-23 | -$992.16K derived: sum of 3 quarters · filed 2016-03-23 | -$937.78K 10-K · filed 2016-03-23 | ||||
| 2014-09-30 | $104.01K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$320.14K derived: sum of 2 quarters · filed 2015-11-10 | -$265.75K 10-Q · filed 2015-11-10 | $919.25K derived: sum of 4 quarters · filed 2015-11-10 | ||||
| 2014-06-30 | -$424.15K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$369.77K 10-Q · filed 2015-08-11 | $815.24K derived: sum of 3 quarters · filed 2015-08-11 | $1.14M derived: sum of 4 quarters · filed 2015-08-11 | ||||
| 2014-03-31 | $54.38K 10-Q · filed 2015-05-12 | $1.24M derived: sum of 2 quarters · filed 2015-05-12 | $1.56M derived: sum of 3 quarters · filed 2015-05-12 | $1.34M derived: sum of 4 quarters · filed 2015-05-12 | ||||
| 2013-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $1.51M derived: sum of 2 quarters · filed 2015-03-09 | $1.29M derived: sum of 3 quarters · filed 2015-03-09 | $1.61M 10-K · filed 2015-03-09 | ||||
| 2013-09-30 | $323.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $103.63K derived: sum of 2 quarters · filed 2014-11-10 | $423.97K 10-Q · filed 2014-11-10 | $591.88K derived: sum of 4 quarters · filed 2014-11-10 | ||||
| 2013-06-30 | -$220.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $100.16K 10-Q · filed 2014-08-11 | $268.06K derived: sum of 3 quarters · filed 2014-08-11 | $367.96K derived: sum of 4 quarters · filed 2014-08-11 | ||||
| 2013-03-31 | $320.34K 10-Q · filed 2014-05-12 | $488.25K derived: sum of 2 quarters · filed 2014-05-12 | $588.14K derived: sum of 3 quarters · filed 2014-05-12 | $870.16K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | $167.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $267.80K derived: sum of 2 quarters · filed 2014-03-28 | $549.82K derived: sum of 3 quarters · filed 2014-03-28 | -$244.74K 10-K · filed 2014-03-28 | ||||
| 2012-09-30 | $99.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $381.91K derived: sum of 2 quarters · filed 2013-11-12 | -$412.65K 10-Q · filed 2013-11-12 | -$464.90K derived: sum of 4 quarters · filed 2013-11-12 | ||||
| 2012-06-30 | $282.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$512.54K 10-Q · filed 2013-08-12 | -$564.79K derived: sum of 3 quarters · filed 2013-08-12 | -$428.07K derived: sum of 4 quarters · filed 2013-08-12 | ||||
| 2012-03-31 | -$794.56K 10-Q · filed 2013-05-14 | -$846.81K derived: sum of 2 quarters · filed 2013-05-14 | -$710.08K derived: sum of 3 quarters · filed 2013-05-14 | -$762.42K derived: sum of 4 quarters · filed 2013-05-14 | ||||
| 2011-12-31 | -$52.24K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-06 | $84.48K derived: sum of 2 quarters · filed 2013-03-06 | $32.14K derived: sum of 3 quarters · filed 2013-03-06 | $40.16K 10-K · filed 2013-03-06 | ||||
| 2011-09-30 | $136.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | $84.39K derived: sum of 2 quarters · filed 2012-11-13 | $92.40K 10-Q · filed 2012-11-13 | |||||
| 2011-06-30 | -$52.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | -$44.32K 10-Q · filed 2012-08-14 | ||||||
| 2011-03-31 | $8.02K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |